Clene Inc stock is traded at $3.97, with a volume of 117,200. It is down -3.17% in the last 24 hours and up +1.53% over the past month. Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Previous Close:
$4.10
Open:
$4.04
24h Volume:
117,200
Relative Volume:
2.16
Market Cap:
$57.17M
Revenue:
$134.00K
Net Income/Loss:
-$33.51M
P/E Ratio:
-
EPS:
-$3.21
Net Cash Flow:
-$18.15M
1W Performance:
+1.79%
1M Performance:
+1.53%
6M Performance:
-39.67%
1Y Performance:
-63.17%
1-Day Range:
$3.63$4.24
1-Week Range:
$3.61$4.28
52-Week Range:
$3.02$11.59
Clene Inc Stock (CLNN) Company Profile
Name
Clene IncSector
HealthcareIndustry
BiotechnologyPhone
801-676-9695Address
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS